M1. Manipulation of Blood and Blood Components
If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.
The following are prohibited:
- The Administration or reintroduction of any quantity of autologous, allogenic (homologous) or heterologous blood or red blood cell products of any origin into the circulatory system.
- Artificially enhancing the uptake, transport or delivery of oxygen. Including, but not limited to: Perfluorochemicals, efaproxiral (RSR13) and modified haemoglobin products e.g. haemoglobin-based blood substitutes and microencapsulated haemoglobin products, excluding supplemental oxygen.
- Any form of intravascular manipulation of the blood or blood components by physical or chemical means.